Moleculera | Prolog Ventures

RECENT NEWS

BioSymetrics and Moleculera Partner to Advance Personalized Treatment for Immune-mediated Neuropsychiatric Disorders

October 1, 2024

Moleculera Labs announces rebrand to Moleculera Biosciences as company expands into new sectors

Moleculera Forms Collaboration with Quest Diagnostics to Broaden Access to its Neuropsychiatric Autoantibody Testing

January 17, 2024

Moleculera Labs Awarded $500,000 Grant Funding to Develop Predictive Treatment Algorithm

January 11, 2024

Moleculera and General Genomics to Provide Personalized Medicine for Neuropsychiatric Disorders